Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.36% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 0.89% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
11376
LENZ Therapeutics
LENZ
$147M
| $34.3K | ﹤0.01% |
+1,975
| New | +$34.3K |
|
11377
PUT
Protalix BioTherapeutics
PLX
$193M
| $34.2K | ﹤0.01% |
20,600
-23,800
| -54% | -$42.7K |
|
11378
Oramed Pharmaceuticals
ORMP
$217M
| $34.1K | ﹤0.01% |
13,068
-74,435
| -85% | -$234K |
|
11379
RF Industries
RFIL
$116M
| $34.1K | ﹤0.01% |
11,313
-985
| -8% | -$3.6K |
|
11380
PUT
ESS Tech
GWH
$14.9M
| $34K | ﹤0.01% |
+1,207
| New | +$29.4K |
|
11381
Heritage Global
HGBL
$41.2M
| $34K | ﹤0.01% |
10,904
-16,991
| -61% | -$57.7K |
|
11382
OmniAb Inc Warrant
OABIW
$28.1M
| $33.9K | ﹤0.01% |
+30,543
| New | +$32.3K |
|
11383
Citius Pharmaceuticals
CTXR
$16.6M
| $33.9K | ﹤0.01% |
1,980
-4,029
| -67% | -$95.8K |
|
11384
Future FinTech Group
FTFT
$22M
| $33.8K | ﹤0.01% |
194
+129
| +198% | +$27.7K |
|
|
ISPO
11385
DELISTED
Inspirato
ISPO
| $33.8K | ﹤0.01% |
2,866
-783
| -21% | -$12.9K |
|
11386
CLPS Inc
CLPS
$31.9M
| $33.8K | ﹤0.01% |
+33,768
| New | +$35.4K |
|
11387
Genasys
GNSS
$76.1M
| $33.7K | ﹤0.01% |
16,785
+6,088
| +57% | +$18.1K |
|
11388
PUT
FreightCar America
RAIL
$238M
| $33.6K | ﹤0.01% |
12,600
+1,000
| +9% | +$2.85K |
|
11389
PUT
Ocugen
OCGN
$475M
| $33.6K | ﹤0.01% |
84,100
-48,600
| -37% | -$24K |
|
11390
Siebert Financial
SIEB
$85.5M
| $33.6K | ﹤0.01% |
+16,899
| New | +$37.6K |
|
11391
CALL
Scilex Holding
SCLX
$39.7M
| $33.6K | ﹤0.01% |
+686
| New | +$94K |
|
11392
CALL
Purple Innovation
PRPL
$20.7M
| $33.5K | ﹤0.01% |
784
-620
| -44% | -$38.7K |
|
11393
Oxford Square Capital
OXSQ
$148M
| $33.3K | ﹤0.01% |
11,051
-255,706
| -96% | -$773K |
|
|
FRSX
11394
Foresight Autonomous Holdings
FRSX
$4.91M
| $32.9K | ﹤0.01% |
+767
| New | +$41.6K |
|
|
11395
CALL
FreightCar America
RAIL
$238M
| $32.8K | ﹤0.01% |
12,300
-9,400
| -43% | -$26.8K |
|
|
VLD
11396
DELISTED
Velo3D, Inc.
VLD
| $32.7K | ﹤0.01% |
598
-6,126
| -91% | -$380K |
|
11397
Wheels Up
UP
$181M
| $32.5K | ﹤0.01% |
786
-1,293
| -62% | -$52.1K |
|
|
CLSD
11398
CALL
DELISTED
Clearside Biomedical
CLSD
| $32.5K | ﹤0.01% |
2,487
-1,233
| -33% | -$18.7K |
|
|
ISPO
11399
PUT
DELISTED
Inspirato
ISPO
| $32.4K | ﹤0.01% |
2,745
+1,245
| +83% | +$20.6K |
|
11400
Dominari Holdings
DOMH
$62.1M
| $32.4K | ﹤0.01% |
+13,432
| New | +$38K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.